A
Alpha-Gen
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | B | 5 | 6.8 | 5.4 | 7.6 | 24 Apr 2025 |
| Tirzepatide | B | 5 | 6.6 | 5.5 | 7.0 | 24 Apr 2025 |
| BPC-157 | C | 5 | 5.5 | 4.6 | 6.4 | 24 Apr 2025 |
| Retatrutide | D | 5 | 6.2 | 4.0 | 7.8 | 24 Apr 2025 |
| CJC-1295 | D | 5 | 4.9 | 3.6 | 6.6 | 24 Apr 2025 |
| Ipamorelin | E | 5 | 5.8 | 1.9 | 7.2 | 24 Apr 2025 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | B | 2 | 5.8 | 4.1 | 7.4 | 26 Jan 2026 |
| ACE-031 | B | 2 | 5.5 | 5.5 | 5.6 | 25 May 2026 |
| Aromasin (Exemestane) | B | 2 | 6.4 | 5.2 | 7.6 | 19 Jan 2026 |
| BAC Water | B | 3 | 6.8 | 6.1 | 7.6 | 17 May 2026 |
| BMK methyl glycidate CAS 80532-66-7 | B | 2 | 6.0 | 5.5 | 6.4 | 26 Jan 2026 |
| Boldenone Cypionate | B | 3 | 5.9 | 5.0 | 7.3 | 23 May 2026 |
| Botulinum toxin | X | 1 | 6.0 | 6.0 | 6.0 | 13 Jun 2025 |
| Cerebrolysin | B | 2 | 4.7 | 3.6 | 5.8 | 21 May 2026 |
| CJC-1295 With DAC | X | 1 | 7.6 | 7.6 | 7.6 | 8 Jul 2025 |
| Cortagen | B | 2 | 5.2 | 4.5 | 5.8 | 24 May 2026 |
| DNP | B | 2 | 6.5 | 6.0 | 7.0 | 17 May 2026 |
| EPO | X | 1 | 6.1 | 6.1 | 6.1 | 3 Jul 2025 |
| Equipoise (Boldenone Undecylenate) | B | 3 | 7.9 | 6.3 | 9.3 | 24 May 2026 |
| GHRP-6 Acetate | B | 3 | 6.4 | 5.8 | 6.9 | 21 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X | 1 | 5.8 | 5.8 | 5.8 | 7 May 2025 |
| GW-501516 (Cardarine) | B | 3 | 6.0 | 5.3 | 6.7 | 26 Jan 2026 |
| HMG | B | 2 | 7.0 | 6.4 | 7.6 | 26 Jan 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | B | 2 | 4.2 | 4.1 | 4.3 | 24 May 2026 |
| KPV Oral | B | 2 | 6.1 | 3.7 | 8.4 | 26 Jan 2026 |
| Lipo-C FAT BLASTER | X | 1 | 6.7 | 6.7 | 6.7 | 7 May 2025 |
| Methylene Blue | B | 2 | 5.2 | 3.7 | 6.8 | 21 May 2026 |
| Metribolone | B | 3 | 7.0 | 3.6 | 8.8 | 17 May 2026 |
| MOTS-C | B | 2 | 6.5 | 6.4 | 6.5 | 19 Jan 2026 |
| MT-1 | B | 3 | 6.9 | 6.4 | 7.5 | 26 Jan 2026 |
| N-Acetyl Epitalon Amidate | X | 1 | 7.1 | 7.1 | 7.1 | 13 Jun 2025 |
| Nitroethane CAS 79-24-3 | X | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 |
| Orforglipron | X | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| Ovagen | B | 3 | 5.9 | 5.0 | 6.9 | 21 May 2026 |
| Primobolan E Raw | B | 2 | 6.8 | 5.1 | 8.5 | 25 May 2026 |
| Prostamax | B | 2 | 5.8 | 5.2 | 6.3 | 17 May 2026 |
| Proviron (Mesterolone) | B | 3 | 5.7 | 4.1 | 6.5 | 17 May 2026 |
| S-23 Raw | B | 3 | 6.6 | 5.4 | 8.2 | 26 Jan 2026 |
| Semaglutide Oral | B | 2 | 5.9 | 5.3 | 6.5 | 25 May 2026 |
| Sustanon 400 | B | 2 | 6.5 | 5.9 | 7.1 | 25 May 2026 |
| Tesofensine | B | 3 | 5.6 | 5.0 | 6.2 | 21 May 2026 |
| Tren Hex | X | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 |
| VIP | B | 2 | 4.7 | 3.1 | 6.3 | 21 May 2026 |
| Winstrol Oil | B | 3 | 6.4 | 5.6 | 7.7 | 24 May 2026 |
| YK11 | B | 3 | 7.1 | 5.0 | 10.0 | 26 Jan 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.2 | 5g | 5.3g | +5.6% | 97.00% | Lab B |
| 25 May 2026 | DNP | 6.9 | 10mg | 8.6mg | -13.6% | 96.68% | Lab F |
| 25 May 2026 | KPV Oral | 4.0 | 25mg | 29.0mg | +15.8% | 96.88% | Lab F |
| 25 May 2026 | Metribolone | 5.7 | 100mg/ml | 96.8mg/ml | -3.2% | 96.92% | Lab G |
| 25 May 2026 | Proviron (Mesterolone) | 4.0 | 100mg | 90.2mg | -9.8% | 99.54% | Lab C |
| 25 May 2026 | Tesofensine | 4.0 | 10mg | 9.5mg | -5.2% | 96.35% | Lab B |
| 24 May 2026 | Botulinum toxin | 6.0 | 10mg | 9.7mg | -2.8% | 97.54% | Lab C |
| 24 May 2026 | KPV Oral | 4.0 | 100mg | 88.6mg | -11.4% | 96.36% | Lab B |
| 24 May 2026 | Sustanon 400 | 6.9 | 200mg/ml | 246.0mg/ml | +23.0% | 97.88% | Lab D |
| 24 May 2026 | VIP | 5.3 | 50mg | 60.0mg | +20.1% | 97.32% | Lab F |
| 24 May 2026 | Cerebrolysin | 4.0 | 50mg | 52.7mg | +5.3% | 99.20% | Lab D |
| 24 May 2026 | Prostamax | 5.7 | 30mg | 33.6mg | +11.8% | 99.64% | Lab G |
| 24 May 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 5.3 | 10g | 8.6g | -14.4% | 96.68% | Lab D |
| 24 May 2026 | Boldenone Cypionate | 7.7 | 200mg/ml | 186.2mg/ml | -6.9% | 97.64% | Lab F |
| 24 May 2026 | DNP | 6.0 | 10mg | 8.9mg | -10.6% | 98.79% | Lab F |
| 24 May 2026 | Lipo-C FAT BLASTER | 7.0 | 300mg/ml | 299.4mg/ml | -0.2% | 96.09% | Lab B |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.8 | 5mg | 5.8mg | +15.8% | 95.01% | Lab F |
| 24 May 2026 | MT-1 | 5.5 | 2mg | 1.8mg | -9.7% | 95.89% | Lab B |
| 24 May 2026 | Proviron (Mesterolone) | 4.3 | 25mg | 22.4mg | -10.6% | 98.12% | Lab D |
| 24 May 2026 | ACE-031 | 5.2 | 10mg | 12.5mg | +24.7% | 99.72% | Lab A |
| 24 May 2026 | GHRP-6 Acetate | 7.6 | 10mg | 10.2mg | +2.0% | 95.01% | Lab B |
| 24 May 2026 | Winstrol Oil | 4.7 | 300mg/ml | 280.5mg/ml | -6.5% | 97.24% | Lab F |
| 23 May 2026 | BAC Water | 6.5 | 50mg | 57.7mg | +15.3% | 96.07% | Lab F |
| 23 May 2026 | GHRP-6 Acetate | 6.2 | 2mg | 1.7mg | -14.5% | 99.46% | Lab E |
| 23 May 2026 | Cortagen | 5.2 | 30mg | 31.6mg | +5.4% | 97.30% | Lab B |
| 23 May 2026 | HMG | 8.5 | 5mg | 4.9mg | -1.4% | 96.56% | Lab A |
| 23 May 2026 | MT-1 | 5.5 | 2mg | 2.4mg | +17.6% | 96.00% | Lab D |
| 21 May 2026 | BAC Water | 6.9 | 30mg | 32.5mg | +8.5% | 98.88% | Lab A |
| 21 May 2026 | Primobolan E Raw | 6.3 | 5g | 5.9g | +17.9% | 97.30% | Lab E |
| 21 May 2026 | Semaglutide Oral | 4.5 | 10mg | 11.1mg | +11.3% | 95.77% | Lab D |
| 21 May 2026 | Sustanon 400 | 4.0 | 100mg/ml | 104.8mg/ml | +4.8% | 97.13% | Lab F |
| 20 May 2026 | YK11 | 9.9 | 25mg | 24.8mg | -1.0% | 95.51% | Lab E |
| 19 May 2026 | Aromasin (Exemestane) | 6.9 | 10mg | 11.3mg | +12.9% | 99.62% | Lab E |
| 19 May 2026 | Ovagen | 7.4 | 20mg | 19.6mg | -2.0% | 99.69% | Lab B |
| 17 May 2026 | BAC Water | 9.1 | 2mg | 1.8mg | -7.5% | 97.56% | Lab F |
| 17 May 2026 | Methylene Blue | 6.1 | 10mg | 11.2mg | +11.6% | 98.50% | Lab E |
| 17 May 2026 | MOTS-C | 4.0 | 20mg | 22.7mg | +13.7% | 96.38% | Lab F |
| 29 Jan 2026 | Tesofensine | 5.7 | 50mg | 45.0mg | -10.0% | 96.75% | Lab G |
| 26 Jan 2026 | Nitroethane CAS 79-24-3 | 8.3 | 100g | 103.6g | +3.6% | 97.37% | Lab G |
| 26 Jan 2026 | S-23 Raw | 5.5 | 500g | 584.0g | +16.8% | 99.84% | Lab G |
| 19 Jan 2026 | Cortagen | 4.1 | 30mg | 35.9mg | +19.6% | 97.20% | Lab E |
| 19 Jan 2026 | GW-501516 (Cardarine) | 7.5 | 10mg | 11.1mg | +10.9% | 97.21% | Lab D |
| 19 Jan 2026 | HMG | 8.6 | 50mg | 57.9mg | +15.8% | 96.24% | Lab A |
| 19 Jan 2026 | MOTS-C | 7.9 | 5mg | 5.0mg | +1.0% | 98.24% | Lab D |
| 19 Jan 2026 | VIP | 4.0 | 15mg | 14.8mg | -1.3% | 95.27% | Lab F |
| 9 Jan 2026 | Cerebrolysin | 4.0 | 30mg | 34.3mg | +14.3% | 99.67% | Lab B |
| 7 Jan 2026 | Equipoise (Boldenone Undecylenate) | 10.0 | 250mg/ml | 264.3mg/ml | +5.7% | 95.80% | Lab F |
| 7 Jan 2026 | Equipoise (Boldenone Undecylenate) | 5.6 | 300mg/ml | 313.4mg/ml | +4.5% | 97.11% | Lab A |
| 7 Jan 2026 | Tren Hex | 5.6 | 100mg/ml | 109.2mg/ml | +9.2% | 96.97% | Lab C |
| 7 Jan 2026 | YK11 | 6.5 | 100mg | 89.1mg | -10.9% | 95.87% | Lab A |
| 6 Jan 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 5.4 | 5g | 4.6g | -7.1% | 95.69% | Lab E |
| 6 Jan 2026 | BMK methyl glycidate CAS 80532-66-7 | 5.2 | 100g | 95.8g | -4.2% | 95.53% | Lab A |
| 6 Jan 2026 | Proviron (Mesterolone) | 4.0 | 25mg | 28.3mg | +13.3% | 96.53% | Lab C |
| 29 Dec 2025 | Methylene Blue | 4.9 | 10mg | 8.6mg | -14.2% | 95.91% | Lab D |
| 12 Dec 2025 | Boldenone Cypionate | 5.7 | 300mg/ml | 302.4mg/ml | +0.8% | 96.89% | Lab E |
| 12 Dec 2025 | GW-501516 (Cardarine) | 7.0 | 25mg | 31.2mg | +24.6% | 99.51% | Lab A |
| 12 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.3 | 10mg | 8.6mg | -14.0% | 96.41% | Lab F |
| 12 Dec 2025 | MT-1 | 6.3 | 30mg | 34.6mg | +15.4% | 97.86% | Lab E |
| 12 Dec 2025 | Ovagen | 5.7 | 20mg | 22.4mg | +11.8% | 96.17% | Lab D |
| 12 Dec 2025 | Tesofensine | 6.9 | 20mg | 24.9mg | +24.7% | 99.06% | Lab A |
| 12 Dec 2025 | Winstrol Oil | 5.6 | 200mg/ml | 186.8mg/ml | -6.6% | 97.02% | Lab E |
| 5 Dec 2025 | ACE-031 | 6.1 | 50mg | 50.4mg | +0.8% | 96.30% | Lab F |
| 5 Dec 2025 | Boldenone Cypionate | 5.4 | 200mg/ml | 218.0mg/ml | +9.0% | 96.26% | Lab B |
| 23 Nov 2025 | GW-501516 (Cardarine) | 4.8 | 20mg | 18.1mg | -9.5% | 99.25% | Lab C |
| 23 Nov 2025 | N-Acetyl Epitalon Amidate | 7.5 | 5mg | 4.8mg | -3.3% | 95.04% | Lab B |
| 17 Nov 2025 | CJC-1295 With DAC | 8.5 | 50mg | 49.8mg | -0.4% | 99.62% | Lab F |
| 17 Nov 2025 | Metribolone | 5.2 | 300mg/ml | 255.2mg/ml | -14.9% | 96.69% | Lab A |
| 17 Nov 2025 | S-23 Raw | 5.5 | 100g | 87.5g | -12.5% | 99.59% | Lab C |
| 14 Nov 2025 | Aromasin (Exemestane) | 8.0 | 50mg | 50.1mg | +0.1% | 95.20% | Lab C |
| 5 Nov 2025 | Orforglipron | 6.6 | 100mg | 97.5mg | -2.5% | 96.10% | Lab E |
| 5 Nov 2025 | Winstrol Oil | 4.5 | 100mg/ml | 88.5mg/ml | -11.5% | 97.32% | Lab B |
| 4 Nov 2025 | Ovagen | 6.1 | 5mg | 5.0mg | -0.4% | 95.14% | Lab A |
| 4 Nov 2025 | YK11 | 6.7 | 100mg | 119.5mg | +19.5% | 99.33% | Lab F |
| 17 Oct 2025 | Equipoise (Boldenone Undecylenate) | 9.6 | 200mg/ml | 210.0mg/ml | +5.0% | 98.09% | Lab F |
| 17 Oct 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 5.6 | 50mg | 47.0mg | -6.0% | 97.89% | Lab B |
| 17 Oct 2025 | Primobolan E Raw | 6.5 | 500g | 516.2g | +3.2% | 95.37% | Lab F |
| 9 Oct 2025 | EPO | 6.0 | 30mg | 32.9mg | +9.6% | 95.13% | Lab B |
| 9 Oct 2025 | S-23 Raw | 5.8 | 10g | 12.1g | +21.4% | 96.40% | Lab C |
| 9 Oct 2025 | Semaglutide Oral | 6.5 | 50mg | 60.8mg | +21.7% | 96.06% | Lab F |
| 3 Oct 2025 | GHRP-6 Acetate | 5.7 | 5mg | 5.1mg | +2.3% | 97.43% | Lab B |
| 3 Oct 2025 | Metribolone | 6.9 | 300mg/ml | 326.9mg/ml | +9.0% | 96.84% | Lab G |
| 3 Oct 2025 | Prostamax | 4.5 | 2mg | 2.0mg | +1.1% | 98.77% | Lab A |
| 21 May 2025 | Tirzepatide | 5.5 | 10mg | 10.7mg | +7.0% | Black Label / Silver Crimp / Red Cap | |
| 21 May 2025 | Semaglutide | 5.4 | 5mg | 5.4mg | +8.0% | Black Label / Silver Crimp / White Cap | |
| 21 May 2025 | Retatrutide | 4.0 | 5mg | 5.7mg | +14.0% | Black Label / Silver Crimp / Green Cap | |
| 20 May 2025 | CJC-1295 | No DAC | 6.6 | 2mg | 2.02mg | +1.0% | Black Label / Silver Crimp / Purple Cap |
| 20 May 2025 | Ipamorelin | 1.9 | 5mg | 6.27mg | +25.4% | Black Label / Silver Crimp / White Cap | |
| 5 May 2025 | BPC-157 | 5.8 | 5mg | 5.58mg | +11.6% | Black Label / Silver Crimp / Red Cap | |
| 2 May 2025 | BPC-157 | 5.4 | 5mg | 5.21mg | +4.2% | Black Label / Silver Crimp / Red Cap |